Pharma-Bio Serv Q2 FY2022 revenue $5.0M, net income $0.2M; stable YoY

Pharma-Bio Serv, Inc.

Revenue for Q2 ended April 30, 2022 was ~$5.0M, up ~$0.1M from prior-year quarter.
Net income for Q2 was ~$0.2M, reflecting no significant change YoY.
Six-month revenue ~$10.0M, net income ~$0.5M, both essentially flat YoY.
CEO cites steady execution and focus on client services amid global uncertainties.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.